Arax Advisory Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $185K | Buy |
2,631
+1,635
| +164% | +$115K | 0.01% | 677 |
|
|
2025
Q1 | $67.5K | Sell |
996
-1,556
| -61% | -$105K | ﹤0.01% | 849 |
|
|
2024
Q4 | $115K | Buy |
2,552
+569
| +29% | +$25.5K | 0.01% | 637 |
|
|
2024
Q3 | $125K | Sell |
1,983
-132
| -6% | -$8.3K | 0.01% | 450 |
|
|
2024
Q2 | $125K | Buy |
2,115
+1,995
| +1,663% | +$118K | 0.01% | 431 |
|
|
2024
Q1 | $9.59K | Sell |
120
-19
| -14% | -$1.52K | ﹤0.01% | 782 |
|
|
2023
Q4 | $11K | Sell |
139
-7
| -5% | -$553 | ﹤0.01% | 752 |
|
|
2023
Q3 | $10.2K | Sell |
146
-49
| -25% | -$3.42K | ﹤0.01% | 716 |
|
|
2023
Q2 | $13.5K | Buy |
195
+40
| +26% | +$2.77K | ﹤0.01% | 657 |
|
|
2023
Q1 | $11.5K | Buy |
155
+31
| +25% | +$2.3K | ﹤0.01% | 666 |
|
|
2022
Q4 | $11.6K | Sell |
124
-160
| -56% | -$14.9K | ﹤0.01% | 630 |
|
|
2022
Q3 | $27K | Buy |
284
+146
| +106% | +$13.9K | ﹤0.01% | 521 |
|
|
2022
Q2 | $13K | Buy |
138
+25
| +22% | +$2.36K | ﹤0.01% | 615 |
|
|
2022
Q1 | $11K | Buy |
113
+63
| +126% | +$6.13K | ﹤0.01% | 640 |
|
|
2021
Q4 | $5K | Buy |
50
+25
| +100% | +$2.5K | ﹤0.01% | 754 |
|
|
2021
Q3 | $2K | Sell |
25
-200
| -89% | -$16K | ﹤0.01% | 839 |
|
|
2021
Q2 | $19K | Buy |
+225
| New | +$19K | ﹤0.01% | 583 |
|
|
2020
Q4 | $29K | Sell |
425
-77
| -15% | -$5.25K | ﹤0.01% | 467 |
|
|
2020
Q3 | $29K | Sell |
502
-1,501
| -75% | -$86.7K | ﹤0.01% | 438 |
|
|
2020
Q2 | $130K | Hold |
2,003
| – | – | 0.02% | 217 |
|
|
2020
Q1 | $119K | Buy |
2,003
+25
| +1% | +$1.49K | 0.03% | 207 |
|
|
2019
Q4 | $147K | Hold |
1,978
| – | – | 0.04% | 198 |
|
|
2019
Q3 | $125K | Sell |
1,978
-1,021
| -34% | -$64.5K | 0.04% | 212 |
|
|
2019
Q2 | $163K | Buy |
+2,999
| New | +$163K | 0.05% | 166 |
|
|
2018
Q4 | $183K | Buy |
2,796
+755
| +37% | +$49.4K | 0.07% | 132 |
|
|
2018
Q3 | $161K | Buy |
2,041
+553
| +37% | +$43.6K | 0.06% | 137 |
|
|
2018
Q2 | $95K | Buy |
1,488
+114
| +8% | +$7.28K | 0.04% | 161 |
|
|
2018
Q1 | $85K | Sell |
1,374
-886
| -39% | -$54.8K | 0.04% | 150 |
|
|
2017
Q4 | $163K | Sell |
2,260
-352
| -13% | -$25.4K | 0.07% | 113 |
|
|
2017
Q3 | $212K | Sell |
2,612
-180
| -6% | -$14.6K | 0.1% | 85 |
|
|
2017
Q2 | $225K | Buy |
2,792
+536
| +24% | +$43.2K | 0.11% | 82 |
|
|
2017
Q1 | $177K | Buy |
2,256
+734
| +48% | +$57.6K | 0.09% | 76 |
|
|
2016
Q4 | $120K | Buy |
+1,522
| New | +$120K | 0.06% | 102 |
|